MSInsight
Paris · Founded 2022
About MSInsight
MSInsight bioinformatics start-up that develops diagnostic and treatment response prediction solutions for Microsatellite Instability (MSI) cancers. Its service offering focuses on diagnostic and prognostic biomarkers of treatment response for MSI tumors.
Company Facts
- Founded: 2022
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $1.7M
- Funding stage: Seed
- Last round: Seed (Mar 2025)
- Website: http://www.msinsight.tech/
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/msinsight-40563 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.